Related Experiment Video

Updated: Jul 5, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

[Management of diabetes mellitus in young children]

Luis Eduardo P Calliari1, Osmar Monte

  • 1Unidade de Endocrinologia Pediátrica, Departamento de Pediatria, Faculdade de Ciências Médicas, Santa Casa de São Paulo, SP, Brasil. caliari@uol.com.br

Arquivos Brasileiros De Endocrinologia E Metabologia
|April 29, 2008
PubMed

Insights

Type 1 diabetes in young children is rare but increasing globally. Early diagnosis and intensive, individualized family-centered care are crucial for managing this condition due to unique challenges in this age group.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Metabolic Disorders

Background:

  • Type 1 diabetes mellitus (T1DM) in children under 5 years old is uncommon but shows a rising global incidence.
  • Diagnosis is often delayed, with patients frequently presenting with advanced ketoacidosis.
  • Young children's dependency necessitates early and comprehensive family involvement in T1DM management.

Purpose of the Study:

  • To highlight the challenges and critical management strategies for type 1 diabetes in very young children.
  • To emphasize the importance of early diagnosis and tailored treatment approaches.

Main Methods:

  • This study reviews current literature and clinical guidelines on pediatric type 1 diabetes management.
  • Focuses on the specific physiological and behavioral characteristics of children under 5 years old.

Main Results:

  • Delayed diagnosis is common, leading to severe complications like ketoacidosis.
  • Children under 5 exhibit atypical hypoglycemic symptoms, irregular eating and activity patterns, and heightened insulin sensitivity.
  • Individualized insulin therapy and consistent glucose monitoring are paramount for effective glycemic control.

Conclusions:

  • Intensive, family-centered care is essential for managing T1DM in children under 5.
  • Individualized treatment plans and vigilant monitoring are key to preventing complications and achieving good metabolic outcomes.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...